In-situ & operando organiC electrochemical transistors monitored by non-destructive spectroscopies for Organic cmos-like NeuromorphIc Circuits

Ultra-flexible, conformable and implantable artificial intelligence organic electronic devices hold promise to revolutionize the real-time monitoring and treatment of chronic diseases.

Such devices are based on organic electrochemical transistors (OECTs) exploiting polymeric mixed ion-to-electron conductors (PMIECs) as active layers.

However, the development of efficient and stable devices is hindered by limited knowledge about structure-property relationships of PMIECs.ICONIC combines macromolecular synthesis with in situ and operando non-destructive spectroscopic methods in an innovative way to investigate with unprecedented accuracy ion-to-electron transduction in OECTs, from the molecular to the micrometre scale.

This provides the key knowledge to make a technological leap in development of smart therapeutic devices.As a proof of concept, ICONIC develops an intelligent closed-loop device for drug-delivery activation.

In a long-term vision, healthcare devices will enable signal recognition with body-friendly electronics and administer medication without the risk of human error.ICONIC is a multidisciplinary high-risk/high-gain project engaging 8 partners from 6 countries covering the academic and industrial worlds (including 1 SME).

The implementation is facilitated through 4 work packages (3 technical). The complementary scientific skills brought in by the partners and stakeholders maximizes ICONIC’s impact.